International Stem Cell (ISCO) Inventory Average (2011 - 2026)
International Stem Cell (ISCO) posted quarterly Inventory Average of $1.6 million for Q4 2025, up 22.58% year-over-year from $1.3 million in Q4 2024, and down 1.15% quarter-over-quarter from $1.6 million in Q3 2025.
International Stem Cell (ISCO) Inventory Average (2011 - 2026) Analysis & Trends
International Stem Cell (ISCO) has reported Inventory Average for 15 consecutive years, with $1.6 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Inventory Average rose 22.58% year-over-year to $1.6 million; the TTM figure through Dec 2025 stood at $1.6 million (up 22.58% YoY), while the FY2025 annual figure was $1.3 million, up 10.41% from the prior year.
- Inventory Average retreated to $1.6 million in Q4 2025 per ISCO's latest filing, from $1.6 million in the prior quarter.
- Across five years, Inventory Average topped out at $1.6 million in Q3 2025 and bottomed at $986000.0 in Q1 2021.
- Historically, Inventory Average has averaged $1.3 million across 5 years, with a median of $1.3 million in 2023.
- Annual changes were most pronounced in 2021 — Inventory Average decreased 15.94% — and 2022, when it advanced 27.08%.
- International Stem Cell's Inventory Average stood at $1.2 million in 2021, then climbed by 20.49% to $1.4 million in 2022, then decreased by 7.82% to $1.3 million in 2023, then slipped by 1.82% to $1.3 million in 2024, then rose by 22.58% to $1.6 million in 2025.
- Business Quant data shows ISCO's Inventory Average at $1.6 million in Q4 2025, $1.6 million in Q3 2025, and $1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | International Stem Cell | 4.32 Mn | 3.23 Mn | 1.46 Mn | 1.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.60 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.57 Mn |
| Jun 30, 2025 | 1.40 Mn |
| Mar 31, 2025 | 1.20 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.27 Mn |
| Dec 31, 2023 | 1.29 Mn |
| Sep 30, 2023 | 1.31 Mn |
| Jun 30, 2023 | 1.30 Mn |
| Mar 31, 2023 | 1.34 Mn |
| Dec 31, 2022 | 1.40 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.25 Mn |
| Dec 31, 2021 | 1.16 Mn |
| Sep 30, 2021 | 1.11 Mn |
| Jun 30, 2021 | 1.06 Mn |